reported that FCPR16, a synthesized PDE4 inhibitor, possesses protective effects against cerebral ischemia–reperfusion injury in rats through the cyclic adenosine monophosphate/cAMP response element‐binding protein pathway (Chen et al., 2018). This evidence concerns the gene PDE4A and brain ischemia.